ENTITY
Legend Biotech Corp

Legend Biotech Corp (LEGN US)

97
Analysis
Health CareChina
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
09 Jun 2024 16:00

China Healthcare Weekly (Jun.9) - New Akeso-Summit Deal, Jacobio Is a Good Bet, Genscript's Trouble

​The new Akeso-Summit deal may pave the way for MNC to acquire Summit.Jacobio is a good target for potential M&A/license deal.Genscript faces US...

Logo
602 Views
Share
25 May 2024 14:00

Legend Biotech Corporation: Implementation of Commercial Launch of CARVYKTI & Other Major Drivers

Legend Biotech Corporation is a biotech company specializing in CAR-T cell therapy for the treatment of multiple myeloma. In Quarter 1 2024, two...

Logo
759 Views
Share
03 Apr 2024 08:55

Legend Biotech Corp (LEGN.US) - FDA's Upcoming Decision on Carvykti Will Change the Whole Landscape

If Carvykti's approved for 2L therapy, it will be a game changer in MM treatment. But Legend Bio's market value performance may be inferior to...

Logo
558 Views
Share
26 Mar 2024 15:00

Legend Biotech Corporation: Initiation of Coverage - Can They Flourish In The Competitive CAR-T Therapy Market? - Major Drivers

This is our first report on biopharma player, Legend Biotech. The company's Q4 earnings call displayed a balance of positive and negative...

Logo
246 Views
Share
bullishBeiGene
19 Feb 2024 08:55

BeiGene (6160.HK/​BGNE.US/688235.CH) - 2023 Results Preview and Undervaluation Concerns

BeiGene's sluggish share price could be related to geopolitical conflicts/weak market sentiment. But there’s no need for US to sanction China's...

Logo
431 Views
Share
x